365 related articles for article (PubMed ID: 24797965)
21. Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
Lelli G; Montanari M; Gilli G; Scapoli D; Antonietti C; Scapoli D
J Chemother; 2003 Jun; 15(3):220-5. PubMed ID: 12868546
[TBL] [Abstract][Full Text] [Related]
22. [Cancer cachexia assessment: new tools for oncologists.].
Serpe R; Demurtas L; Puzzoni M; Madeddu C; Scartozzi M
Recenti Prog Med; 2016 Oct; 107(10):515-524. PubMed ID: 27782227
[TBL] [Abstract][Full Text] [Related]
23. Update on emerging drugs for cancer cachexia.
Murphy KT; Lynch GS
Expert Opin Emerg Drugs; 2009 Dec; 14(4):619-32. PubMed ID: 19860537
[TBL] [Abstract][Full Text] [Related]
24. The "parallel pathway": a novel nutritional and metabolic approach to cancer patients.
Muscaritoli M; Molfino A; Gioia G; Laviano A; Rossi Fanelli F
Intern Emerg Med; 2011 Apr; 6(2):105-12. PubMed ID: 20596799
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
[TBL] [Abstract][Full Text] [Related]
26. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
27. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
[TBL] [Abstract][Full Text] [Related]
28. Addressing and targeting earnest condition of advance breast cancer-related anorexia and cachexia through Rasayana therapy.
Kadam A; Bendale Y; Birari-Gawande P
J Cancer Res Ther; 2020; 16(6):1210-1214. PubMed ID: 33342775
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia.
Brown JK
Oncol Nurs Forum; 2002 Apr; 29(3):517-32. PubMed ID: 11979284
[TBL] [Abstract][Full Text] [Related]
30. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
[TBL] [Abstract][Full Text] [Related]
31. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
[TBL] [Abstract][Full Text] [Related]
32. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
33. Review article: anorexia and cachexia in gastrointestinal cancer.
Ockenga J; Valentini L
Aliment Pharmacol Ther; 2005 Oct; 22(7):583-94. PubMed ID: 16181298
[TBL] [Abstract][Full Text] [Related]
34. SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).
Rivas AS; Álvarez YE; Cordellat AB; Tarruella MM; Mata KM; de la Cámara MM; Del Mar Muñoz Sánchez M; Poves MZ; Zambrano CB; Gutierrez LC
Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38822976
[TBL] [Abstract][Full Text] [Related]
35. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and wasting in cancer.
Laviano A; Meguid MM; Preziosa I; Rossi Fanelli F
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):449-56. PubMed ID: 17563463
[TBL] [Abstract][Full Text] [Related]
38. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
39. Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review.
Tarricone R; Ricca G; Nyanzi-Wakholi B; Medina-Lara A
Crit Rev Oncol Hematol; 2016 Mar; 99():49-62. PubMed ID: 26775729
[TBL] [Abstract][Full Text] [Related]
40. Metabolic and nutritional aspects of cancer.
Krawczyk J; Kraj L; Ziarkiewicz M; Wiktor-Jędrzejczak W
Postepy Hig Med Dosw (Online); 2014 Aug; 68():1008-14. PubMed ID: 25228508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
